These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immune response of young children vaccinated with Haemophilus influenzae type b conjugate vaccines. Madore DV; Phipps DC; Eby R; Johnson CL; Smith DH Contrib Microbiol Immunol; 1989; 10():125-50. PubMed ID: 2684505 [No Abstract] [Full Text] [Related]
3. Responses of children to booster immunization with their primary conjugate Haemophilus influenzae type B vaccine or with polyribosylribitol phosphate conjugated with diphtheria toxoid. Decker MD; Edwards KM; Bradley R; Palmer P J Pediatr; 1993 Mar; 122(3):410-3. PubMed ID: 8441096 [TBL] [Abstract][Full Text] [Related]
4. Haemophilus influenzae type b polysaccharide-protein conjugate vaccines in children. Eskola J; Takala AK; Käyhty H Curr Opin Pediatr; 1993 Feb; 5(1):55-9. PubMed ID: 8374627 [TBL] [Abstract][Full Text] [Related]
5. Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. Granoff DM; Rathore MH; Holmes SJ; Granoff PD; Lucas AH Vaccine; 1993; 11 Suppl 1():S46-51. PubMed ID: 8447176 [TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys. Vella PP; Ellis RW Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253 [TBL] [Abstract][Full Text] [Related]
8. Statement on Haemophilus influenzae type b conjugate vaccines for use in infants and children. CMAJ; 1993 Jan; 148(2):199-214. PubMed ID: 8452591 [No Abstract] [Full Text] [Related]
9. American Academy of Pediatrics Committee on Infectious Diseases: Haemophilus influenzae type b conjugate vaccines: recommendations for immunization with recently and previously licensed vaccines. Pediatrics; 1993 Sep; 92(3):480-8. PubMed ID: 8361814 [No Abstract] [Full Text] [Related]
10. The 1990s: a decade of new vaccines. Murphy TV Pediatr Infect Dis J; 1991 Feb; 10(2):89-91. PubMed ID: 2062619 [No Abstract] [Full Text] [Related]
11. Prevention of Haemophilus influenzae type b disease: vaccines and passive prophylaxis. Wenger JD; Ward JI; Broome CV Curr Clin Top Infect Dis; 1989; 10():306-39. PubMed ID: 2679698 [No Abstract] [Full Text] [Related]
12. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. Dashefsky B; Wald E; Guerra N; Byers C Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519 [TBL] [Abstract][Full Text] [Related]
13. Disease caused by Haemophilus influenzae type b in the immediate period after homologous immunization: immunologic investigation. Sood SK; Daum RS Pediatrics; 1990 Apr; 85(4 Pt 2):698-704. PubMed ID: 2107522 [TBL] [Abstract][Full Text] [Related]
14. Finnish efficacy trials with Haemophilus influenzae type b vaccines. Eskola J; Peltola H; Käyhty H; Takala AK; Mäkelä PH J Infect Dis; 1992 Jun; 165 Suppl 1():S137-8. PubMed ID: 1588148 [TBL] [Abstract][Full Text] [Related]
15. Haemophilus influenzae type b. Conjugate vaccines for use in infants and children. Hanna JN; Steven ID; Plant AJ Aust Fam Physician; 1993 Jun; 22(6):1015-7, 1020-1. PubMed ID: 8338447 [TBL] [Abstract][Full Text] [Related]
16. Haemophilus b conjugate vaccines for prevention of Haemophilus influenzae type b disease among infants and children two months of age and older. Recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep; 1991 Jan; 40(RR-1):1-7. PubMed ID: 1899280 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB). Vella PP; Staub JM; Armstrong J; Dolan KT; Rusk CM; Szymanski S; Greer WE; Marburg S; Kniskern PJ; Schofield TL Pediatrics; 1990 Apr; 85(4 Pt 2):668-75. PubMed ID: 2107517 [TBL] [Abstract][Full Text] [Related]
18. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines. Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156 [No Abstract] [Full Text] [Related]
19. Vaccines for Haemophilus influenzae type b as models for an otitis vaccine. Mäkelä PH; Käyhty H; Peltola H; Eskola J Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S73-5. PubMed ID: 2648298 [No Abstract] [Full Text] [Related]
20. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants. Hendley JO; Wenzel JG; Ashe KM; Samuelson JS Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]